cilengitide has been researched along with Experimental Mammary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bäuerle, T; Berger, MR; Goodman, SL; Komljenovic, D; Merz, M; Semmler, W | 1 |
1 other study(ies) available for cilengitide and Experimental Mammary Neoplasms
Article | Year |
---|---|
Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study.
Topics: Animals; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Rats; Rats, Nude; Receptors, Vitronectin; Snake Venoms; Tomography, X-Ray Computed | 2011 |